Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein disulfide-isomerase-like protein of the testis (PDILT) is a testis-specific member of the protein disulfide isomerase (PDI) family that functions as a redox-inactive chaperone, uniquely expressed in postmeiotic male germ cells during spermatid differentiation and spermatogenesis[1][2][3][4][5]. Unlike many PDI family proteins, PDILT lacks the canonical catalytic cysteines required for oxidoreductase activity and instead operates via chaperone-mediated protein folding in the endoplasmic reticulum, where it forms a complex with the testis-specific lectin chaperone calmegin[1][2][4]. This partnership is critical for the maturation of sperm cells and proper folding of spermatogenesis-specific glycoproteins[2]. Mutations or deficiencies in PDILT or its partners result in male infertility due to defective sperm differentiation or acrosome formation[1][2]. PDILT is not known as a direct drug target or therapeutic receptor/enzyme/transporter and no drugs are currently reported to interact with it[3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein disulfide-isomerase-like protein of the testis (PDILT).